Interleukin-2/NN
promoter/NN
activity/NN
in/IN
Epstein-Barr/JJ
virus-transformed/JJ
B/NN
lymphocytes/NNS
is/VBZ
controlled/VBN
by/IN
nuclear/JJ
factor-chi/NN
B/NN
./.

The/DT
regulation/NN
of/IN
interleukin/NN
(/(
IL/NN
)/)
-2/CD
gene/NN
expression/NN
has/VBZ
been/VBN
investigated/VBN
mainly/RB
in/IN
T/NN
lymphocytes/NNS
,/,
the/DT
predominant/JJ
producers/NNS
of/IN
IL-2/NN
./.
=====
However/RB
,/,
B/NN
cells/NNS
can/MD
also/RB
synthesize/VB
IL-2/NN
./.
=====
In/IN
the/DT
present/JJ
study/NN
we/PRP
analyzed/VBD
the/DT
control/NN
of/IN
IL-2/NN
promoter/NN
activity/NN
in/IN
Epstein-Barr/JJ
virus/NN
(/(
EBV/NN
)/)
-transformed/JJ
B/NN
cell/NN
clones/NNS
which/WDT
are/VBP
capable/JJ
of/IN
secreting/VBG
IL-2/NN
at/IN
a/DT
low/JJ
level/NN
after/IN
stimulation/NN
with/IN
phorbol/NN
12-myristate/NN
13-acetate/NN
and/CC
the/DT
Ca2+/NN
ionophore/NN
ionomycin/NN
./.
=====
Transient/JJ
transfections/NNS
using/VBG
reporter/NN
constructs/NNS
with/IN
multiples/NNS
of/IN
transcription/NN
factor/NN
binding/NN
sites/NNS
from/IN
the/DT
IL-2/NN
promoter/NN
[/(
distal/JJ
nuclear/JJ
factor/NN
(/(
NF/NN
)/)
-AT/NN
,/,
proximal/JJ
NF-AT/NN
,/,
AP-1/Octamer/NN
(/(
UPS/NN
)/)
or/CC
NF-chi/NN
B/NN
(/(
TCEd/NN
)/)
sites/NNS
]/)
were/VBD
performed/VBN
./.
=====
In/IN
EBV-transformed/JJ
B/NN
clones/NNS
,/,
the/DT
chi/NN
B/NN
site/NN
exerted/VBD
the/DT
strongest/JJS
inducible/JJ
activity/NN
;/:
the/DT
NF-AT/NN
binding/NN
sites/NNS
showed/VBD
either/CC
no/DT
or/CC
only/RB
weak/JJ
activity/NN
compared/VBN
to/TO
Jurkat/NN
T/NN
cells/NNS
./.
=====
An/DT
IL-2/NN
promoter/NN
bearing/VBG
a/DT
defective/JJ
NF-chi/NN
B/NN
site/NN
was/VBD
completely/RB
inactive/JJ
in/IN
EBV-transformed/NN
B/NN
cells/NNS
,/,
while/IN
it/PRP
still/RB
had/VBD
activity/NN
in/IN
Jurkat/NN
T/NN
cells/NNS
./.
=====
In/IN
seven/CD
EBV-B/NN
cell/NN
clones/NNS
or/CC
lines/NNS
differing/VBG
in/IN
their/PRP$
capacity/NN
to/TO
secrete/VB
IL-2/NN
,/,
the/DT
activity/NN
of/IN
the/DT
IL-2/NN
promoter/NN
correlated/VBD
well/RB
with/IN
the/DT
status/NN
of/IN
IL-2/NN
secretion/NN
./.
=====
Similarly/RB
,/,
a/DT
human/JJ
immunodeficiency/NN
virus/NN
promoter/NN
,/,
whose/WP$
activity/NN
is/VBZ
controlled/VBN
through/IN
chi/NN
B/NN
factors/NNS
,/,
was/VBD
found/VBN
to/TO
be/VB
active/JJ
in/IN
the/DT
IL-2/NN
producing/NN
EBV-B/NN
cells/NNS
,/,
but/CC
inactive/JJ
in/IN
the/DT
non-IL-2-producing/JJ
cells/NNS
./.
=====
Electrophoretic/JJ
mobility/NN
shift/NN
assays/NNS
using/VBG
protein/NN
extracts/NNS
from/IN
EBV-B/NN
cells/NNS
and/CC
the/DT
IL-2/NN
NF-chi/NN
B/NN
probe/NN
revealed/VBD
the/DT
constitutive/JJ
generation/NN
of/IN
chi/NN
B/NN
complexes/NNS
in/IN
IL-2-secreting/NN
cells/NNS
consisting/VBG
mainly/RB
of/IN
heterodimeric/JJ
p50/p65/NN
complexes/NNS
./.
=====
A/DT
weaker/JJR
chi/NN
B/NN
complex/JJ
formation/NN
and/CC
faster-migrating/JJ
complexes/NNS
were/VBD
detected/VBN
in/IN
non-IL-2-secreting/JJ
cells/NNS
./.
=====
These/DT
results/NNS
demonstrate/VBP
that/IN
the/DT
IL-2/NN
NF-chi/NN
B/NN
site/NN
is/VBZ
indispensable/JJ
for/IN
the/DT
activity/NN
of/IN
the/DT
IL-2/NN
promoter/NN
in/IN
EBV-transformed/JJ
B/NN
cells/NNS
,/,
whereas/IN
other/JJ
transcription/NN
factors/NNS
appear/VBP
to/TO
be/VB
less/RBR
important/JJ
for/IN
IL-2/NN
expression/NN
in/IN
these/DT
cells/NNS
./.